Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trop2/EpCAM PET/CT for NSCLC Diagnosis
NCT07026110Recruiting
- Sponsor
- Renji Hospital
- Start
- Dec 2024
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Renji Hospital. Primary endpoints: Biodistribution-Standardized uptake value (SUV) of normal tissues and organs at 1 day, Standardized uptake value (SUV) of tumors at 1 day and 6 more. Started Dec 2024; status: recruiting.
Beyond the preview
Go deeper on NCT07026110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07026110.